You are viewing: Asia Pacific Structural Heart Devices Market analysis

The Asia Pacific Structural Heart Devices Market was valued at $3765.9 Million in 2024 and projected to reach to $6116.2 Million by 2029, representing a compound annual growth rate of 10.2%. The Asia Pacific structural heart devices market is positioned for sustained growth through 2029, with the region's 10.2% CAGR reflecting strong fundamentals including demographic shifts, healthcare modernization, and rising cardiovascular disease prevalence.

Asia Pacific Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific Structural Heart Devices Market Trends and Insights

  • Asia Pacific's market growth is driven by rising prevalence of structural heart conditions, aging populations across the region, and increasing healthcare infrastructure investments.
  • The region's 10.2% compound annual growth rate outpaces global trends, reflecting strong demand for minimally invasive cardiac interventions and improved patient access to advanced treatment options. Asia Pacific represents a critical growth frontier for structural heart device manufacturers, with emerging economies in Southeast Asia and South Asia contributing significantly to market expansion.
  • Between 2024 and 2029, Asia Pacific is expected to capture increasing market share as regulatory frameworks mature and reimbursement pathways expand across key markets including China, India, Japan, and Australia.
  • The region's growing middle class and rising healthcare spending are accelerating adoption of transcatheter and percutaneous structural heart solutions..

Key Market Statistics

  • CAGR (2024-2029) 10.2% CAGR
  • Market Size, 2024 ~USD 3765.9 Million
  • Forecast, 2029 ~USD 6116.2 Million
  • Geography Asia Pacific

Asia Pacific Structural Heart Devices Market Overview

Rapid Market Expansion :

Asia Pacific structural heart devices market is growing at 10.2% CAGR, outpacing the global rate of 9.5%, driven by increasing adoption of minimally invasive procedures and advanced cardiac interventions across the region.

Aging Population Dynamics :

Rapidly aging demographics in Japan, China, and South Korea are significantly increasing the prevalence of structural heart conditions, creating sustained demand for innovative device solutions and interventional treatments.

Healthcare Infrastructure Investment :

Major investments in healthcare infrastructure across India, China, and Southeast Asia are expanding access to structural heart device therapies, improving hospital capabilities, and enabling wider patient treatment options.

Market Leadership by Key Nations :

Japan ($977.6M) and China ($929.7M) dominate the Asia Pacific market, while India ($629.3M) represents the fastest-growing emerging opportunity with increasing cardiac intervention centers and rising healthcare spending.

Asia Pacific Structural Heart Devices Market Dynamics

  • Japan and China maintain market leadership, while India emerges as a high-growth opportunity driven by expanding middle-class populations and improved healthcare accessibility. Key growth catalysts include increasing adoption of transcatheter interventions, growing awareness of structural heart conditions, and regulatory approvals for advanced devices.
  • Healthcare providers across the region are investing in specialized cardiac centers and interventional capabilities, supporting market expansion.
  • Strategic partnerships between global device manufacturers and regional healthcare systems are accelerating market penetration and driving innovation tailored to Asia Pacific patient populations..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Asia Pacific structural heart devices market will grow from $3,765.9M (2024) to $6,116.2M (2029) at a 10.2% CAGR, outpacing global growth rates.
    • Aging demographics and rising cardiovascular disease prevalence across Asia Pacific are primary drivers of structural heart device adoption.
    • Emerging markets in Southeast Asia and South Asia present untapped growth opportunities as healthcare infrastructure and reimbursement expand.
    • Minimally invasive transcatheter solutions are gaining traction in Asia Pacific due to shorter recovery times and reduced hospital burden.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    Asia Pacific Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    Target Audience

    • Medical Device Manufacturers : Strategic planning for Asia Pacific market entry, expansion, and product localization requires detailed regional market sizing, growth forecasts, and country-specific opportunity assessment to optimize commercial investments.
    • Healthcare Investors & PE Firms : Investment decision-making in Asia Pacific cardiac care infrastructure, device distribution networks, and healthcare facilities demands comprehensive market data, growth trajectories, and regional economic indicators.
    • Hospital & Healthcare Systems : Procurement planning, capital equipment budgeting, and service line development in structural heart programs require market intelligence on device availability, pricing trends, and clinical adoption patterns across Asia Pacific.
    • Regulatory & Government Bodies : Policy development, healthcare reimbursement frameworks, and medical device regulations across Asia Pacific benefit from market analysis, adoption trends, and comparative regional healthcare spending data.
    • Consulting & Market Research Firms : Client advisory services, competitive analysis, and market strategy development for Asia Pacific healthcare clients require validated market data, regional insights, and country-level performance metrics.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 9635.2 Million · 10% wtd CAGR ·
    Europe
    ~USD 7398.8 Million · 9% wtd CAGR ·
    Latin America
    ~USD 1659.2 Million · 7.8% wtd CAGR ·
    Middle East & Africa
    ~USD 883.2 Million · 7.7% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    JapanUSD 977.6 Million
    ChinaUSD 929.7 Million
    IndiaUSD 629.3 Million
    AustraliaUSD 246.6 Million
    South KoreaUSD 206.6 Million
    Rest Of Asia PacificUSD 274.9 Million

    Country market size visualization

    Japan
    USD 977.6 Million
    China
    USD 929.7 Million
    India
    USD 629.3 Million
    Australia
    USD 246.6 Million
    South Korea
    USD 206.6 Million
    Rest Of Asia Pacific
    USD 274.9 Million

    Reasons to Buy this Report

    • Regional Growth Opportunity : Capture insights into the fastest-growing structural heart device market segment with 10.2% CAGR, outpacing global growth and offering superior expansion potential compared to mature Western markets.
    • Country-Specific Market Intelligence : Access detailed market sizing and growth trajectories for Japan, China, India, Australia, and South Korea, enabling targeted market entry strategies and resource allocation decisions for Asia Pacific expansion.
    • Demographic and Clinical Trends : Understand aging population dynamics, rising structural heart disease prevalence, and evolving treatment patterns specific to Asia Pacific, informing product development and clinical positioning strategies.
    • Healthcare Infrastructure Insights : Leverage analysis of regional healthcare investments, hospital capabilities, and interventional center expansion to identify partnership opportunities and market penetration strategies across diverse healthcare systems.
    • Competitive Positioning Data : Benchmark market performance across Asia Pacific countries and identify white-space opportunities in emerging markets like India and Southeast Asia for competitive advantage and market share growth.

    Frequently asked questions

    What is the current market size of structural heart devices in Asia Pacific?

    The Asia Pacific structural heart devices market was valued at $3,765.9 million in 2024 and is expected to grow to $6,116.2 million by 2029.

    What is the projected growth rate for Asia Pacific structural heart devices?

    Asia Pacific's structural heart devices market is projected to grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2029.

    Which countries drive the Asia Pacific structural heart devices market?

    Key markets in Asia Pacific include China, Japan, India, Australia, and Southeast Asian nations, which collectively represent the largest demand for structural heart interventions.

    What factors are driving growth in the Asia Pacific structural heart devices market?

    Growth drivers include aging populations, rising cardiovascular disease prevalence, expanding healthcare infrastructure, improving reimbursement policies, and increasing adoption of minimally invasive procedures.

    How does Asia Pacific's growth compare to the global structural heart devices market?

    Asia Pacific's 10.2% CAGR exceeds the global market CAGR of 9.5%, indicating the region is growing faster than the worldwide average and gaining market share.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status